Customize your JAMA Network experience by selecting one or more topics from the list below.
Clark D, Woods J, Patki D, et al. Digital Informed Consent in a Rural and Low-Income Population. JAMA Cardiol. 2020;5(7):845–847. doi:10.1001/jamacardio.2020.0984
Rural and minority populations are underrepresented in clinical research, likely because of travel barriers and financial resources required to participate in conventional studies.1 Digital technology holds promise to improve access to clinical studies,2 but limited evidence is available detailing the adoption of these methods in underserved populations. We describe our experience using digital technology for remote enrollment in a clinical study evaluating the use of home blood pressure (BP) telemonitoring for hypertension management.
This prospective study at the University of Mississippi Medical Center (UMMC) used data for participants enrolled from September 4, 2018, through September 19, 2019. The study protocol was approved by the UMMC institutional review board. Adult patients with hypertension and uncontrolled BP who were receiving outpatient care at UMMC were eligible for study inclusion.
Potential participants were identified by referral and review of the electronic health record. Following a screening telephone call, interested individuals meeting eligibility criteria were mailed a telemonitoring kit, including an electronic tablet with prepaid secure broadband connectivity, wireless BP cuff, and institutional review board–approved consent document. There were no costs incurred by study participants. The consent document was written at an eighth-grade reading level using lay terminology and formatted to facilitate clear understanding of the content. After receiving the kit, the research coordinator (K.J.) contacted the participant via the tablet for an audiovisual encounter. During the audiovisual encounter, personal identifying information was confirmed and the consent form reviewed, with the ability to screen-share the document in real time. The research coordinator, who was well versed in the cultural exigencies of this patient population, addressed any questions or concerns. Informed consent was authorized by the participant by agreeing to a confirmatory statement displayed on the tablet, which generated a time and date electronic stamp transmitted to the individual’s electronic health record. The research coordinator documented the encounter in the electronic health record, including a description of the consent process. If the individual declined to participate, the kit was returned at no cost to the participant in a prepaid shipping box. Data analysis was completed with Excel version 16.0.12624 (Microsoft).
Among 100 enrolled participants, the mean (SD) age was 59.6 (11.1) years; 54 participants (54%) were female, and 45 (45%) were African American (Table). Twenty-three participants (23%) resided in a rural county, and 43 (43%) reported household income of less than $30 000 per year (Figure). Ten participants (10%) provided informed consent during a work break. Two participants were unable to complete enrollment because of insufficient device connectivity.
In this study using digital consent among individuals recruited from a broad population of individuals with hypertension, a substantial number of successfully enrolled participants were female, African American, and/or reporting a household income at or near the poverty level. Furthermore, more than 1 in 5 participants resided in a federally designated rural county. Electronic consent has been pioneered in smartphone app studies and internet-based clinical trials and represents a promising area to expand access and enhance medical research.3-5 However, many prior studies involving digital technology have included predominately white populations with higher socioeconomic status, raising concern for a growing digital divide among underserved populations.6 The present study adds to prior work by demonstrating the utility of digital consent and remote study enrollment to facilitate inclusion of populations underrepresented in clinical research.
The sample size enrolled is encouraging for our single-center study at an academic medical center; however, this consent strategy should be evaluated in other research environments to determine generalizability for other clinical trials. Additionally, further platform development is needed to optimize information exchange, participant understanding, and integration of digital consent into the larger research infrastructure. In conclusion, these findings support the use of digital technology to expand opportunities to participate in clinical research in underserved populations.
Accepted for Publication: March 10, 2020.
Corresponding Author: Donald Clark III, MD, MPH, Division of Cardiology, Department of Medicine, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216 (email@example.com).
Published Online: May 13, 2020. doi:10.1001/jamacardio.2020.0984
Author Contributions: Dr Clark had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Clark, D. Jones, Summers.
Acquisition, analysis, or interpretation of data: Clark, Woods, Patki, K. Jones, Stasher.
Drafting of the manuscript: Clark, Stasher.
Critical revision of the manuscript for important intellectual content: Clark, Woods, Patki, K. Jones, D. Jones, Summers.
Obtained funding: Clark, D. Jones.
Administrative, technical, or material support: Clark, Patki, K. Jones, Stasher, D. Jones.
Supervision: Clark, D. Jones, Summers.
Conflict of Interest Disclosures: None reported.
Funding/Support: The University of Mississippi Medical Center received grants from Federal Office of Rural Health Policy, Health Resources and Services Administration, and the US Department of Health and Human Services under cooperative agreement award 6 U66RH31459-02-03 that supported this study. Dr Clark received support from the American Heart Association (award 19CDA34760232) during the conduct of the study. Additional support was received from the National Institute of General Medical Sciences/National Institutes of Health (grant 5U54GM115428).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The information, conclusions, and opinions expressed are those of the authors, and no endorsement by Federal Office of Rural Health Policy, Health Resources and Services Administration, and the US Department of Health and Human Services is intended or should be inferred.
Create a personal account or sign in to: